A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: Application to critically ill pediatric patients: Journal of Pharmaceutical and Biomedical Analysis

S. Barco, A. Mesini, L. Barbagallo, A. Maffia, G. Tripodi, F. Pea, C. Saffioti, E. Castagnola, G. Cangemi

Research output: Contribution to journalArticlepeer-review

Abstract

Background: The accurate measurement of plasma levels of antibiotics is crucial for the individualization of antimicrobial therapies based on PK/PD strategies. In this paper we describe a new rapid and simple LC–MS/MS platform for quantifying 14 antibiotics (amikacin, amoxicillin, ceftazidime, ciprofloxacin, colistin, daptomycin, gentamicin, linezolid, meropenem, piperacillin, teicoplanin, tigecycline, tobramycin and vancomycin) and a beta-lactamase inhibitor (tazobactam) starting from 50 μL plasma samples. Methods: Analyses were performed on a Thermo Scientific™ Ultimate™ 3000 LC system (Thermo Fisher Scientific, Milan, Italy) coupled to a Thermo Scientific™ TSQ Quantiva™ Triple Quadrupole mass spectrometer. After fast protein precipitation protocols and addition of deuterated internal standards, samples were subjected to a fast HPLC gradient separation and the 15 drugs were quantified using multiple reaction monitoring of specific transitions over a wide range of concentrations. The suitability of the assay for TDM was tested on plasma samples derived from pediatric patients under treatment with one or more antibiotics. Results: The overall turnaround time of the assay was 20 min. The assay was validated following EMA guidelines for bioanalytical method validation and showed excellent accuracy (ranging from 85.3 and 112.7) and reproducibility (ranging from 1.3 to 9.7) as well as the absence of matrix effects (
Original languageEnglish
JournalJ. Pharm. Biomed. Anal.
Volume186
DOIs
Publication statusPublished - 2020

Keywords

  • Antibiotics
  • Liquid chromatography-tandem mass spectrometry
  • Pediatric
  • Therapeutic drug monitoring
  • amikacin
  • amoxicillin
  • antibiotic agent
  • ceftazidime
  • ciprofloxacin
  • colistin
  • daptomycin
  • gentamicin
  • linezolid
  • meropenem
  • piperacillin
  • tazobactam
  • teicoplanin
  • tigecycline
  • tobramycin
  • vancomycin
  • accuracy
  • antibiotic therapy
  • Article
  • critically ill patient
  • drug blood level
  • drug monitoring
  • drug retention
  • drug stability
  • human
  • limit of quantitation
  • liquid chromatography-mass spectrometry
  • matrix effect
  • multiple reaction monitoring
  • pediatric patient
  • priority journal
  • reproducibility
  • retention time
  • turnaround time
  • ultra performance liquid chromatography
  • validation process

Fingerprint

Dive into the research topics of 'A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: Application to critically ill pediatric patients: Journal of Pharmaceutical and Biomedical Analysis'. Together they form a unique fingerprint.

Cite this